{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:15:38Z","timestamp":1788264938510,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":62,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jvoice.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:25:11Z","timestamp":1784924711000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term and Longitudinal Outcomes of Intracordal Trafermin Injection in Vocal Fold Paralysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-9461","authenticated-orcid":false,"given":"Tomohiro","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3314-5890","authenticated-orcid":false,"given":"Retsu","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2026.07.008_bib1","unstructured":"Fibroblast growth factor regeneration of tympanic membrane perforations. Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT04960384. [Accessed February 27, {C}2026].{C}."},{"key":"10.1016\/j.jvoice.2026.07.008_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.anl.2025.02.003","article-title":"The long-term stability after regeneration therapy for tympanic membrane perforation","volume":"52","author":"Takahashi","year":"2025","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jvoice.2026.07.008_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anl.2023.09.003","article-title":"Outcomes of regenerative treatment for over 200 patients with tympanic membrane perforation","volume":"51","author":"Kanai","year":"2024","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jvoice.2026.07.008_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00784-024-05979-7","article-title":"Periodontal regenerative therapy using recombinant human fibroblast growth factor (rhFGF)-2 in combination with carbonate apatite granules or rhFGF-2 alone: 12-month randomized controlled trial","volume":"28","author":"Imamura","year":"2024","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jvoice.2026.07.008_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.matbio.2024.12.011","article-title":"FGF and TGF-\u03b2 growth factor isoform modulation of human gingival and periodontal ligament fibroblast wound healing phenotype","volume":"136","author":"Guo","year":"2025","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jvoice.2026.07.008_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/lary.70220","article-title":"Investigation of optimal trafermin dosage and pre-injection factors in vocal fold paralysis","volume":"136","author":"Hasegawa","year":"2025","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.07.008_bib7","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1002\/lary.32436","article-title":"Predictors of voice improvement after intracordal trafermin injection in vocal fold paralysis","volume":"135","author":"Hasegawa","year":"2025","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.07.008_bib8","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/lary.70360","article-title":"Efficacy of intracordal trafermin injection using propensity score matching in age-related vocal fold atrophy","volume":"136","author":"Hasegawa","year":"2026","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.07.008_bib9","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jvoice.2023.03.017","article-title":"One year outcomes and longitudinal changes in voice improvement with single high dose intracordal trafermin injections for age-related vocal fold atrophy","volume":"39","author":"Hasegawa","year":"2023","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.07.008_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/000348940511400409","article-title":"Regeneration of aged vocal folds with basic fibroblast growth factor in a rat model: a preliminary report","volume":"114","author":"Hirano","year":"2005","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2026.07.008_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40463-023-00647-4","article-title":"Effects of early local administration of high-dose bFGF on a recurrent laryngeal nerve injury model","volume":"52","author":"Goto","year":"2023","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2026.07.008_bib12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jvoice.2021.01.015","article-title":"Effect of a single injection of basic fibroblast growth factor into the vocal folds: a 36-month clinical study","volume":"37","author":"Miura","year":"2023","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.07.008_bib13","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1002\/lary.25315","article-title":"Single injection of basic fibroblast growth factor to treat severe vocal fold lesions and vocal fold paralysis","volume":"125","author":"Kanazawa","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.07.008_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/lio2.806","article-title":"Long-term results and safety of fibroblast growth factor injection for unilateral vocal fold paralysis","volume":"7","author":"Yamauchi","year":"2022","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.jvoice.2026.07.008_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bjsm.2005.024455","article-title":"Angiogenic effect of intramuscular administration of basic fibroblast growth factor in atrophied muscles: an experimental study in the rat","volume":"40","author":"Efthimiadou","year":"2006","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jvoice.2026.07.008_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1302\/0301-620X.82B1.0820131","article-title":"Growth factors improve muscle healing in vivo","volume":"82","author":"Menetrey","year":"2000","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jvoice.2026.07.008_bib17","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1097\/MLG.0b013e3181845720","article-title":"Regeneration of aged vocal fold: first human case treated with fibroblast growth factor","volume":"118","author":"Hirano","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.07.008_bib18","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/lary.29200","article-title":"Intracordal injection of basic fibroblast growth factor in 100 cases of vocal fold atrophy and scar","volume":"131","author":"Hirano","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.07.008_bib19","series-title":"Applied Mixed Models in Medicine","author":"Brown","year":"2015"},{"key":"10.1016\/j.jvoice.2026.07.008_bib20","series-title":"Generalized, Linear, and Mixed Models","author":"McCulloch","year":"2008"},{"key":"10.1016\/j.jvoice.2026.07.008_bib21","first-page":"53","article-title":"A review of generalized linear mixed models","volume":"143","author":"Molenberghs","year":"2002","journal-title":"J Soc Fr Stat"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199726003620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199726003620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:34:10Z","timestamp":1788262450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199726003620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"alternative-id":["S0892199726003620"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2026.07.008","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term and Longitudinal Outcomes of Intracordal Trafermin Injection in Vocal Fold Paralysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The Voice Foundation.","name":"copyright","label":"Copyright"}]}}